Mass antibiotic administration for eradication of ocular Chlamydia trachomatis

JAMA

Volumn 299, Issue 7, 2008, Pages 819-821

  Mabey, David ^a   Solomon, Anthony W ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC THERAPY; BLINDNESS; CHLAMYDIA TRACHOMATIS; CONGENITAL HYPOTHYROIDISM; CORNEA OPACITY; EDITORIAL; ERADICATION THERAPY; EYE INFECTION; HUMAN; INFECTION CONTROL; PREVALENCE; PRIORITY JOURNAL; SINGLE DRUG DOSE; NOTE; TRACHOMA;

ANTI-BACTERIAL AGENTS; AZITHROMYCIN; HUMANS; TRACHOMA;

EID: 39549089926     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.299.7.819     Document Type: Editorial

References (25)

1. Mariotti SP. New steps toward eliminating blinding trachoma. N Engl J Med. 2004;351(19):2004-2007.
2. Resnikoff S, Pascolini D, Etya'ale D, et al. Global data on visual impairment in the year 2002. Bull World Health Organ. 2004;82(11):844-851.
3. Mabey DC, Solomon AW, Foster A. Trachoma. Lancet. 2003;362(9379):223-229.
4. Bailey RL, Arullendran P, Whittle HC, Mabey DC. Randomised controlled trial of single-dose azithromycin in treatment of trachoma. Lancet. 1993;342(8869):453-456.
5. World Health Organization. Planning for the Global Elimination of Trachoma (GET): Report of a WHO Consultation. Geneva, Switzerland: World Health Organization; 1997. WHO/PBL/97.60. .
6. Kumaresan J. Can blinding trachoma be eliminated by 20/20. Eye. 2005;19(10):1067-1073.
7. Ejere H, Alhassan MB, Rabiu M. Face washing promotion for preventing active trachoma. Cochrane Database Syst Rev. 2004;(3):CD003659.
8. Rabiu M, Alhassan M, Ejere H. Environmental sanitary interventions for preventing active trachoma. Cochrane Database Syst Rev. 2007;(4):CD004003.
9. Schachter J, West SK, Mabey D, et al. Azithromycin in control of trachoma. Lancet. 1999;354(9179):630-635.
10. Solomon AW, Holland MJ, Alexander ND, et al. Mass treatment with single-dose azithromycin for trachoma. N Engl J Med. 2004;351(19):1962- 1971.
11. Burton MJ, Holland MJ, Makalo P, et al. Re-emergence of Chlamydia trachomatis infection after mass antibiotic treatment of a trachoma-endemic Gambian community: a longitudinal study. Lancet. 2005;365(9467):1321- 1328.
12. West SK, Munoz B, Mkocha H, et al. Infection with Chlamydia trachomatis after mass treatment of a trachoma hyperendemic community in Tanzania: a longitudinal study. Lancet. 2005;366(9493):1296-1300.
13. Chidambaram JD, Alemayehu W, Melese M, et al. Effect of a single mass antibiotic distribution on the prevalence of infectious trachoma. JAMA. 2006;295(10):1142-1146.
14. Solomon AW, Zondervan M, Kuper H, Buchan JC, Mabey DCW, Foster A. Trachoma Control: A Guide for Program Managers. Geneva, Switzerland: World Health Organization; 2006.
15. Melese M, Chidambaram JD, Alemayehu W, et al. Feasibility of eliminating ocular Chlamydia trachomatis with repeat mass antibiotic treatments. JAMA. 2004;292(6):721-725.
16. Ray KJ, Porco TC, Hong KC, et al. A rationale for continuing mass antibiotic distributions for trachoma. BMC Infect Dis. 2007;7:91.
17. Melese M, Alemayehu W, Lakew T, et al. Comparison of annual and biannual mass antibiotic administration for elimination of infectious trachoma. JAMA. 2008;299(7):778-784.
18. World Health Assembly. Global Elimination of Blinding Trachoma: 51st World Health Assembly. Geneva, Switzerland: World Health Organization; May 16, 1998. Resolution WHA51.11.
19. Grayston JT, Wang SP, Yeh LJ, Kuo CC. Importance of reinfection in the pathogenesis of trachoma. Rev Infect Dis. 1985;7(6):717-725.
20. Harding-Esch E, Solomon A, Massae P, Mabey D. Five year impact of mass azithromycin treatment on trachoma in Rombo District, Tanzania. In: Proceedings of the Eleventh International Symposium on Human Chlamydial Infections; June 18-23, 2006; Niagara-on-the-Lake, Ontario:333-336.
21. Jha H, Chaudary JS, Bhatta R, et al. Disappearance of trachoma from Western Nepal. Clin Infect Dis. 2002;35(6):765-768.
22. Solomon AW, Mohammed Z, Massae PA, et al. Impact of mass distribution of azithromycin on the antibiotic susceptibilities of ocular Chlamydia trachomatis. Antimicrob Agents Chemother. 2005;49(11):4804-4806.
23. Leach AJ, Shelby-James TM, Mayo M, et al. A prospective study of the impact of community-based azithromycin treatment of trachoma on carriage and resistance of Streptococcus pneumoniae. Clin Infect Dis. 1997;24(3):356-362.
24. Fry AM, Jha HC, Lietman TM, et al. Adverse and beneficial secondary effects of mass treatment with azithromycin to eliminate blindness due to trachoma in Nepal. Clin Infect Dis. 2002;35(4):395-402.
25. Batt SL, Charalambous BM, Solomon AW, et al. Impact of azithromycin administration for trachoma control on the carriage of antibiotic-resistant Streptococcus pneumoniae. Antimicrob Agents Chemother. 2003;47(9):2765-2769.